Biotoxtech Co., Ltd. (KOSDAQ: 086040)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,320.00
-30.00 (-0.69%)
Sep 11, 2024, 2:59 PM KST
-42.40%
Market Cap 68.57B
Revenue (ttm) 34.47B
Net Income (ttm) -4.94B
Shares Out 15.93M
EPS (ttm) -310.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,261
Open 4,395.00
Previous Close 4,350.00
Day's Range 4,300.00 - 4,470.00
52-Week Range 4,000.00 - 7,600.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Biotoxtech

Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea. It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development. The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and de... [Read more]

Industry Medical Laboratories
Founded 2000
Employees 214
Stock Exchange KOSDAQ
Ticker Symbol 086040
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.